Opioid Prescriptions After Hemorrhoidectomy. 2020

Pamela W Lu, and Adam C Fields, and Tomas Andriotti, and Vanessa M Welten, and Mehida Rojas-Alexandre, and Tracey P Koehlmoos, and Andrew J Schoenfeld, and Nelya Melnitchouk
Division of General and Gastrointestinal Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Hemorrhoids cause more than 4 million ambulatory care visits in the United States annually, and hemorrhoidectomy is associated with significant postoperative pain. There are currently no evidence-based opioid-prescribing guidelines for hemorrhoidectomy patients. The purpose of this study was to investigate patterns of opioid prescribing and to identify factors associated with opioid refill after hemorrhoidectomy. This was a retrospective database review. The study was conducted using the Department of Defense Military Health System Data Repository (2006-2014). Opioid-naïve patients aged 18 to 64 years enrolled in TRICARE insurance who underwent surgical hemorrhoidectomy were included in this study. We measured patterns of opioid prescriptions and predictors of a second opioid prescription within 2 weeks of the end date for the first prescription after hemorrhoidectomy. A total of 6294 patients were included; 5536 (88.0%) filled an initial opioid prescription with a median 5-day supply, and 1820 (32.9%) required an opioid refill. The modeled risk of refill based on initial prescription supply ranged from a high of 39.2% risk with an initial prescription of 1-day supply to an early nadir (26.1% risk of refill) with an initial 10-day supply. A variety of sociodemographic and clinical characteristics influenced the likelihood of opioid refill, including black race (OR = 0.75 (95% CI, 0.62-0.89)), history of substance abuse (OR = 3.26 (95% CI, 1.37-7.34)), and length of index opioid prescription (4-6 d, OR = 0.83 (95% CI, 0.72-0.96) or ≥7 d, OR = 0.67 (95% CI, 0.57-0.78) vs 1-3 d). Variables assessed were limited because of the use of claims-based data. There is wide variability in the length of prescription opioid use after hemorrhoidectomy. Approximately one third of patients require a second prescription in the immediate postoperative period. The optimal duration appears to be between a 5- and 10-day supply. Clinicians may be able to more efficiently discharge patients with adequate analgesia while minimizing the potential for excess supply. See Video Abstract at http://links.lww.com/DCR/B112. PRESCRIPCIÓN DE MÉDICAMENTOS OPIOIDES DESPUÉS DE HEMORROIDECTOMÍA: Las afecciones hemorroidarias ocasionan anualmente más de cuatro millones de consultas ambulatorias en los Estados Unidos. La hemorroidectomía esta asociada con dolor postoperatorio muy significativo. Actualmente no existen pautas claras para la prescripción de medicamentos opioides después de hemorroidectomía, basada en la evidencia.Investigar los patrones de prescripción de medicamentos opioides e identificar los factores asociados con la acumulación de dichos opioides después de una hemorroidectomía.Revisión retrospectiva de una base de datos.Almacén de datos del Sistema de Salud militar del Departamento de Defensa de los Estados Unidos de América (2006-2014).Todos aquellos sometidos a hemorroidectomía quirúrgica, sin tratamiento opiode previo, comprendiodos entre 18-64 años y beneficiarios de seguro TRICARE.Patrones de prescripción de recetas de opioides, predictores de una segunda receta de opioides dentro las dos semanas posteriores a la fecha de finalización de la primera receta después de la hemorroidectomía.6.294 pacientes fueron incluidos en el estudio. 5.536 (88,0%) completaron una receta inicial de opioides con un suministro promedio de cinco días, y 1.820 (32,9%) pacientes requirieron reabastecerse de opioides. El riesgo modelado de reabastecimiento de opiodes basado en el suministro de la prescripción inicial, varió desde un alto riesgo (39.2%) con una prescripción inicial de suministro por día, hasta un acmé temprano (26.1% de riesgo de reabastecimiento) con un suministro inicial de 10 días. Una gran variedad de características socio-demográficas y clínicas influyeron en la probabilidad del reabastecimeinto de los opioides, incluida la raza negra (OR 0.75, intervalo de confianza (IC) del 95% (0.62, 0.89)), los antecedentes de abuso de substancias (OR 3.26, IC del 95% (1.37, 7.34)) y la duración del índice de la prescripción de opioides (4-6 días (OR 0.83, IC 95% (0.72, 0.96)), o 7 días o más (OR 0.67, IC 95% (0.57, 0,78)) comparados a 1-3 días.Las variables analizadas fueron limitadas debido al uso de datos basados en reclamos.Existe una gran variabilidad en la duración del uso de opioides recetados después de hemorroidectomía. Aproximadamente un tercio de los pacientes requieren una segunda prescripción en el postoperatorio inmediato. La duración óptima parece estar entre un suministro de cinco y 10 días. Los médicos pueden dar de alta de manera más eficiente a los pacientes con analgesia adecuada y minimizar el potencial de exceso de suministro. Consulte Video Resumen en http://links.lww.com/DCR/B112. (Traducción-Dr. Xavier Delgadillo).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009293 Opioid-Related Disorders Disorders related to or resulting from abuse or misuse of OPIOIDS. Opiate Addiction,Opiate Dependence,Opioid Misuse,Opioid Use Disorder,Prescription Opioid Abuse,Prescription Opioid Misuse,Addiction, Opioid,Dependence, Opioid,Opiate Abuse,Opioid Abuse,Opioid Addiction,Opioid Dependence,Abuse, Opiate,Abuse, Opioid,Abuse, Prescription Opioid,Addiction, Opiate,Dependence, Opiate,Disorder, Opioid Use,Misuse, Opioid,Misuse, Prescription Opioid,Opiate Abuses,Opioid Abuse, Prescription,Opioid Abuses,Opioid Addictions,Opioid Dependences,Opioid Misuses,Opioid Related Disorders,Opioid Use Disorders,Opioid-Related Disorder,Prescription Opioid Abuses,Prescription Opioid Misuses
D010149 Pain, Postoperative Pain during the period after surgery. Acute Post-operative Pain,Acute Postoperative Pain,Chronic Post-operative Pain,Chronic Post-surgical Pain,Chronic Postoperative Pain,Chronic Postsurgical Pain,Pain, Post-operative,Persistent Postsurgical Pain,Post-operative Pain,Post-operative Pain, Acute,Post-operative Pain, Chronic,Post-surgical Pain,Postoperative Pain, Acute,Postoperative Pain, Chronic,Postsurgical Pain,Postoperative Pain,Acute Post operative Pain,Chronic Post operative Pain,Chronic Post surgical Pain,Chronic Postsurgical Pains,Pain, Acute Post-operative,Pain, Acute Postoperative,Pain, Chronic Post-operative,Pain, Chronic Post-surgical,Pain, Chronic Postoperative,Pain, Chronic Postsurgical,Pain, Persistent Postsurgical,Pain, Post operative,Pain, Post-surgical,Pain, Postsurgical,Post operative Pain,Post operative Pain, Acute,Post operative Pain, Chronic,Post surgical Pain,Post-operative Pains,Post-surgical Pain, Chronic,Postsurgical Pain, Chronic,Postsurgical Pain, Persistent
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000081322 Military Health Services Services organized for the diagnosis and treatment of disease and the maintenance of health primarily of MILITARY PERSONNEL. Military Health System,Health Service, Military,Health System, Military,Military Health Service,Military Health Systems,Service, Military Health,System, Military Health
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000701 Analgesics, Opioid Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. Opioid,Opioid Analgesic,Opioid Analgesics,Opioids,Full Opioid Agonists,Opioid Full Agonists,Opioid Mixed Agonist-Antagonists,Opioid Partial Agonists,Partial Opioid Agonists,Agonist-Antagonists, Opioid Mixed,Agonists, Full Opioid,Agonists, Opioid Full,Agonists, Opioid Partial,Agonists, Partial Opioid,Analgesic, Opioid,Full Agonists, Opioid,Mixed Agonist-Antagonists, Opioid,Opioid Agonists, Full,Opioid Agonists, Partial,Opioid Mixed Agonist Antagonists,Partial Agonists, Opioid

Related Publications

Pamela W Lu, and Adam C Fields, and Tomas Andriotti, and Vanessa M Welten, and Mehida Rojas-Alexandre, and Tracey P Koehlmoos, and Andrew J Schoenfeld, and Nelya Melnitchouk
January 2018, Journal of surgical orthopaedic advances,
Pamela W Lu, and Adam C Fields, and Tomas Andriotti, and Vanessa M Welten, and Mehida Rojas-Alexandre, and Tracey P Koehlmoos, and Andrew J Schoenfeld, and Nelya Melnitchouk
August 2021, Journal of pediatric orthopedics,
Pamela W Lu, and Adam C Fields, and Tomas Andriotti, and Vanessa M Welten, and Mehida Rojas-Alexandre, and Tracey P Koehlmoos, and Andrew J Schoenfeld, and Nelya Melnitchouk
January 2021, JSLS : Journal of the Society of Laparoendoscopic Surgeons,
Pamela W Lu, and Adam C Fields, and Tomas Andriotti, and Vanessa M Welten, and Mehida Rojas-Alexandre, and Tracey P Koehlmoos, and Andrew J Schoenfeld, and Nelya Melnitchouk
February 2021, Canadian journal of surgery. Journal canadien de chirurgie,
Pamela W Lu, and Adam C Fields, and Tomas Andriotti, and Vanessa M Welten, and Mehida Rojas-Alexandre, and Tracey P Koehlmoos, and Andrew J Schoenfeld, and Nelya Melnitchouk
January 2015, Journal of opioid management,
Pamela W Lu, and Adam C Fields, and Tomas Andriotti, and Vanessa M Welten, and Mehida Rojas-Alexandre, and Tracey P Koehlmoos, and Andrew J Schoenfeld, and Nelya Melnitchouk
February 2019, JAMA,
Pamela W Lu, and Adam C Fields, and Tomas Andriotti, and Vanessa M Welten, and Mehida Rojas-Alexandre, and Tracey P Koehlmoos, and Andrew J Schoenfeld, and Nelya Melnitchouk
January 2022, World journal of pediatric surgery,
Pamela W Lu, and Adam C Fields, and Tomas Andriotti, and Vanessa M Welten, and Mehida Rojas-Alexandre, and Tracey P Koehlmoos, and Andrew J Schoenfeld, and Nelya Melnitchouk
April 2025, JAMA network open,
Pamela W Lu, and Adam C Fields, and Tomas Andriotti, and Vanessa M Welten, and Mehida Rojas-Alexandre, and Tracey P Koehlmoos, and Andrew J Schoenfeld, and Nelya Melnitchouk
December 2016, JAMA,
Pamela W Lu, and Adam C Fields, and Tomas Andriotti, and Vanessa M Welten, and Mehida Rojas-Alexandre, and Tracey P Koehlmoos, and Andrew J Schoenfeld, and Nelya Melnitchouk
September 2018, Annals of family medicine,
Copied contents to your clipboard!